Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics: Thomas Slavin

Myriad Genetics has named Thomas Slavin as its new chief medical officer. Slavin, who will report to Myriad Genetics Laboratories President Nicole Lambert, joined the company in March last year. Prior to that, he was an assistant professor within City of Hope National Medical Center's medical oncology and therapeutics research and population sciences departments. Slavin has developed guidelines for colorectal cancer screening and genetic testing within National Comprehensive Cancer Network committees, and classified genetic variants associated with breast, gastrointestinal, and ovarian cancer risk within ClinGen expert working groups.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.